{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:03:47Z","timestamp":1768716227962,"version":"3.49.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"National Institute of Health","doi-asserted-by":"publisher","award":["NS051715"],"award-info":[{"award-number":["NS051715"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health","doi-asserted-by":"publisher","award":["AG030539"],"award-info":[{"award-number":["AG030539"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health","doi-asserted-by":"publisher","award":["AG044817"],"award-info":[{"award-number":["AG044817"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["ZEN-14-283969"],"award-info":[{"award-number":["ZEN-14-283969"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bright Focus Foundation","award":["A2015275S)"],"award-info":[{"award-number":["A2015275S)"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.nbd.2015.10.003","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T13:37:46Z","timestamp":1445434666000},"page":"130-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Oxidative stress and mitochondria-mediated cell death mechanisms triggered by the familial Danish dementia ADan amyloid"],"prefix":"10.1016","volume":"85","author":[{"given":"Krysti","family":"Todd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Ghiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agueda","family":"Rostagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nbd.2015.10.003_bb0005","first-page":"200","article-title":"Mitochondrial metabolism of reactive oxygen species","volume":"70","author":"Andreyev","year":"2005","journal-title":"Biokhimiya\/Biochemistry"},{"issue":"4","key":"10.1016\/j.nbd.2015.10.003_bb0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/bst0300557","article-title":"Properties of neurotoxic peptides related to the BRI gene","volume":"30","author":"Austen","year":"2002","journal-title":"Biochem. Soc. Trans."},{"issue":"11","key":"10.1016\/j.nbd.2015.10.003_bb0015","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bjo.84.11.1298","article-title":"Ocular changes in heredo-oto-ophthalmo-encephalopathy","volume":"84","author":"Bek","year":"2000","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.nbd.2015.10.003_bb0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/cb1001203","article-title":"ANS binding reveals common features of cytotoxic amyloid species","volume":"5","author":"Bolognesi","year":"2010","journal-title":"ACS Chem. Biol."},{"issue":"Journal Article","key":"10.1016\/j.nbd.2015.10.003_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.neuro.31.060407.125529","article-title":"Active and passive immunotherapy for neurodegenerative disorders","volume":"31","author":"Brody","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2015.10.003_bb0030","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0896-6273(02)00604-9","article-title":"Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome","volume":"33","author":"Busciglio","year":"2002","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.nbd.2015.10.003_bb0035","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/cn400146a","article-title":"Benzothiazole Aniline Tetra(ethylene glycol) and 3-Amino-1,2,4-triazole Inhibit Neuroprotection against Amyloid Peptides by Catalase Overexpression in Vitro","volume":"4","author":"Chilumuri","year":"2013","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2015.10.003_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nsb752","article-title":"Kinetic partitioning of protein folding and aggregation","volume":"9","author":"Chiti","year":"2002","journal-title":"Nat. Struct. Biol."},{"issue":"6950","key":"10.1016\/j.nbd.2015.10.003_bb0045","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature01891","article-title":"Rationalization of the effects of mutations on peptide and protein aggregation rates","volume":"424","author":"Chiti","year":"2003","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.nbd.2015.10.003_bb0050","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1073\/pnas.93.7.2996","article-title":"Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein","volume":"93","author":"Davis","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.nbd.2015.10.003_bb0055","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11357-012-9403-0","article-title":"Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Abeta pathology at the lysosome","volume":"35","author":"De Kimpe","year":"2013","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.nbd.2015.10.003_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/44be8a39-d943-419b-a430-c2b30dafadec","article-title":"Amyloid-\u03b2 protofibrils: size, morphology and synaptotoxicity of an engineered mimic","volume":"8","author":"Dubnovitsky","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.10.003_bb0065","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1196\/annals.1299.113","article-title":"Increased apoptotic cell death in sporadic and genetic Alzheimer's disease","volume":"1010","author":"Eckert","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2015.10.003_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1096\/fj.09-139584","article-title":"Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-beta variants in cells composing the cerebral vessel walls","volume":"24","author":"Fossati","year":"2010","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.nbd.2015.10.003_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/BJ20130652","article-title":"Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid beta and the Asn23 Iowa mutation","volume":"456","author":"Fossati","year":"2013","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.nbd.2015.10.003_bb0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ajpath.2013.05.005","article-title":"Pyroglutamate-3 amyloid-beta deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models","volume":"183","author":"Frost","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.nbd.2015.10.003_bb0085","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.112.268946","article-title":"Mitochondrial control of cellular life, stress, and death","volume":"111","author":"Galluzzi","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.nbd.2015.10.003_bb0090","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0169-409X(02)00149-7","article-title":"Amyloidosis and Alzheimer's disease","volume":"54","author":"Ghiso","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.nbd.2015.10.003_bb0095","first-page":"277","article-title":"Chromosome 13 dementia syndromes as models of neurodegeneration","volume":"8","author":"Ghiso","year":"2001","journal-title":"Int. J. Experiment. Clin. Investig."},{"issue":"1","key":"10.1016\/j.nbd.2015.10.003_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1750-3639.2006.tb00563.x","article-title":"Genetic alterations of the BRI2 gene: familial British and Danish dementias","volume":"16","author":"Ghiso","year":"2006","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.nbd.2015.10.003_bb0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1471-4159.2003.02134.x","article-title":"Oligomerization and neurotoxicity of the amyloid ADan peptide implicated in familial Danish dementia","volume":"88","author":"Gibson","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.10.003_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.redox.2013.12.013","article-title":"Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease","volume":"2","author":"Giordano","year":"2014","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.nbd.2015.10.003_bb0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuroscience.2006.08.027","article-title":"High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain","volume":"143","author":"Guntert","year":"2006","journal-title":"Neuroscience"},{"issue":"5054","key":"10.1016\/j.nbd.2015.10.003_bb0120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.nbd.2015.10.003_bb0125","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11095-007-9516-9","article-title":"Extrinsic fluorescent dyes as tools for protein characterization","volume":"25","author":"Hawe","year":"2008","journal-title":"Pharm. Res."},{"issue":"33","key":"10.1016\/j.nbd.2015.10.003_bb0130","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1021\/bi990563r","article-title":"The a beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length a beta","volume":"38","author":"He","year":"1999","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.nbd.2015.10.003_bb0135","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jnen\/61.3.254","article-title":"Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta","volume":"61","author":"Holton","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.10.003_bb0140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.1993.tb23043.x","article-title":"The C-terminus of the beta protein is critical in amyloidogenesis","volume":"695","author":"Jarrett","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2015.10.003_bb0145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0925-4439(01)00097-7","article-title":"Role of glycine-33 and methionine-35 in Alzheimer's amyloid \u03b2-peptide 1\u201342-associated oxidative stress and neurotoxicity","volume":"1586","author":"Kanski","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.nbd.2015.10.003_bb0150","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/14783","article-title":"Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia","volume":"2","author":"Kim","year":"1999","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2015.10.003_bb0155","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1074\/jbc.M108739200","article-title":"Proteolytic processing of familial British dementia-associated BRI variants: evidence for enhanced intracellular accumulation of amyloidogenic peptides","volume":"277","author":"Kim","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.nbd.2015.10.003_bb0160","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1523\/JNEUROSCI.0891-08.2008","article-title":"BRI2 (ITM2b) inhibits Abeta deposition in vivo","volume":"28","author":"Kim","year":"2008","journal-title":"J. Neurosci."},{"issue":"34","key":"10.1016\/j.nbd.2015.10.003_bb0165","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1523\/JNEUROSCI.0620-09.2009","article-title":"The p75 neurotrophin receptor promotes amyloid-beta(1\u201342)-induced neuritic dystrophy in vitro and in vivo","volume":"29","author":"Knowles","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2015.10.003_bb0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0925-4439(98)00014-3","article-title":"Irreversible dimerization\/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease","volume":"1406","author":"Kuo","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.nbd.2015.10.003_bb0175","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/j.ddtec.2012.04.001","article-title":"Animal models of Alzheimer's disease and drug development","volume":"10","author":"Laurijssens","year":"2013","journal-title":"Drug Discov. Today Technol."},{"issue":"3","key":"10.1016\/j.nbd.2015.10.003_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JAD-2004-6311","article-title":"The Amyloid Hypothesis and the clearance and degradation of Alzheimer's beta-peptide","volume":"6","author":"LeVine","year":"2004","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.nbd.2015.10.003_bb0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0092-8674(00)80085-9","article-title":"Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.nbd.2015.10.003_bb0190","doi-asserted-by":"crossref","first-page":"11211","DOI":"10.1074\/jbc.M110.185041","article-title":"N-terminal glutamate to pyroglutamate conversion in vivo for human IgG2 antibodies","volume":"286","author":"Liu","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"31","key":"10.1016\/j.nbd.2015.10.003_bb0195","doi-asserted-by":"crossref","first-page":"22376","DOI":"10.1074\/jbc.M700088200","article-title":"Anti-A beta 1\u201311 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers","volume":"282","author":"Mamikonyan","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2015.10.003_bb0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1326-9-5","article-title":"Amyloid peptides ABri and ADan show differential neurotoxicity in transgenic drosophila models of familial British and Danish dementia","volume":"9","author":"Marcora","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"12","key":"10.1016\/j.nbd.2015.10.003_bb0205","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.nbd.2015.10.003_bb0210","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/BST0380539","article-title":"Alzheimer's disease and amyloid beta-peptide deposition in the brain: a matter of \u2018aging\u2019?","volume":"38","author":"Moro","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2015.10.003_bb0215","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2119\/molmed.2011.00366","article-title":"Beta-amyloid carrying the Dutch mutation has diverse effects on calpain-mediated toxicity in hippocampal neurons","volume":"18","author":"Nicholson","year":"2012","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.nbd.2015.10.003_bb0220","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"7400","key":"10.1016\/j.nbd.2015.10.003_bb0225","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature11060","article-title":"Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta","volume":"485","author":"Nussbaum","year":"2012","journal-title":"Nature"},{"issue":"35","key":"10.1016\/j.nbd.2015.10.003_bb0230","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","article-title":"Structure-neurotoxicity relationships of amyloid beta-protein oligomers","volume":"106","author":"Ono","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.nbd.2015.10.003_bb0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jmb.2005.04.016","article-title":"Prediction of \u201caggregation-prone\u201d and \u201caggregation-susceptible\u201d regions in proteins associated with neurodegenerative diseases","volume":"350","author":"Pawar","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.nbd.2015.10.003_bb0240","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/1570159X11311050004","article-title":"Pyroglutamate-modified amyloid beta peptides: emerging targets for Alzheimer s disease immunotherapy","volume":"11","author":"Perez-Garmendia","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"40","key":"10.1016\/j.nbd.2015.10.003_bb0245","doi-asserted-by":"crossref","first-page":"34186","DOI":"10.1074\/jbc.M501694200","article-title":"Beta-amyloid is different in normal aging and in Alzheimer disease","volume":"280","author":"Piccini","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.nbd.2015.10.003_bb0250","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1124\/mol.111.073916","article-title":"Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis","volume":"80","author":"Pittelli","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.nbd.2015.10.003_bb0255","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00018-009-0182-4","article-title":"Cerebral amyloidosis: amyloid subunits, mutants and phenotypes","volume":"67","author":"Rostagno","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.nbd.2015.10.003_bb0260","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(96)12970-0","article-title":"Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain","volume":"215","author":"Saido","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.nbd.2015.10.003_bb0265","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.neurobiolaging.2012.11.014","article-title":"Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias","volume":"34","author":"Saul","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.nbd.2015.10.003_bb0270","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1515\/BC.2008.111","article-title":"Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution","volume":"389","author":"Schilling","year":"2008","journal-title":"Biol. Chem."},{"issue":"29","key":"10.1016\/j.nbd.2015.10.003_bb0275","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1021\/bi900818a","article-title":"Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides","volume":"48","author":"Schlenzig","year":"2009","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.nbd.2015.10.003_bb0280","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1471-4159.2012.07707.x","article-title":"N-terminal pyroglutamate formation of Abeta38 and Abeta40 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation","volume":"121","author":"Schlenzig","year":"2012","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2015.10.003_bb0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/jsbi.1997.3859","article-title":"The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology","volume":"119","author":"Seilheimer","year":"1997","journal-title":"J. Struct. Biol."},{"issue":"4","key":"10.1016\/j.nbd.2015.10.003_bb0290","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.joca.2008.09.006","article-title":"DNA methylation is not responsible for p21WAF1\/CIP1 down-regulation in osteoarthritic chondrocytes","volume":"17","author":"Sesselmann","year":"2009","journal-title":"Osteoarthr. Cartil."},{"issue":"4","key":"10.1016\/j.nbd.2015.10.003_bb0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10495-008-0187-8","article-title":"Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications","volume":"13","author":"Silva","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.nbd.2015.10.003_bb0300","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yexcr.2008.11.002","article-title":"Dutch and Arctic mutant peptides of beta amyloid(1\u201340) differentially affect the FGF-2 pathway in brain endothelium","volume":"315","author":"Solito","year":"2009","journal-title":"Exp. Cell Res."},{"issue":"13","key":"10.1016\/j.nbd.2015.10.003_bb0305","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 43","key":"10.1016\/j.nbd.2015.10.003_bb0310","first-page":"261","article-title":"Cataract, deafness, cerebellar ataxia, psychosis and dementia\u2014a new syndrome","volume":"46","author":"Stromgren","year":"1970","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.nbd.2015.10.003_bb0315","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1471-4159.2006.04072.x","article-title":"Hierarchy and the mechanism of fibril formation in ADan peptides","volume":"99","author":"Surolia","year":"2006","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2015.10.003_bb0320","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2008.04.169","article-title":"Form and dimensions of aggregates dictate cytotoxicities of Danish dementia peptides","volume":"372","author":"Surolia","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2015.10.003_bb0325","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(99)00872-8","article-title":"Evidence for tissue-specific forms of glutaminyl cyclase","volume":"455","author":"Sykes","year":"1999","journal-title":"FEBS Lett."},{"issue":"12 Pt A","key":"10.1016\/j.nbd.2015.10.003_bb0330","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.bbadis.2014.09.010","article-title":"Mitochondrial dysfunction induced by a post-translationally modified amyloid linked to a familial mutation in an alternative model of neurodegeneration","volume":"1842","author":"Todd","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"44","key":"10.1016\/j.nbd.2015.10.003_bb0335","doi-asserted-by":"crossref","first-page":"36883","DOI":"10.1074\/jbc.M504038200","article-title":"Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A beta) in the absence of compact plaques","volume":"280","author":"Tomidokoro","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.nbd.2015.10.003_bb0340","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s00018-009-8746-x","article-title":"Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells","volume":"66","author":"Viana","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"6738","key":"10.1016\/j.nbd.2015.10.003_bb0345","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/21637","article-title":"A stop-codon mutation in the BRI gene associated with familial British dementia","volume":"399","author":"Vidal","year":"1999","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.nbd.2015.10.003_bb0350","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1073\/pnas.080076097","article-title":"A decamer duplication in the 3\u2032 region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred","volume":"97","author":"Vidal","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.10.003_bb0355","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.nbd.2015.10.003_bb0360","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates","volume":"274","author":"Walsh","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.10.003_bb0365","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates","volume":"274","author":"Walsh","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.nbd.2015.10.003_bb0370","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-009-0557-5","article-title":"Intraneuronal pyroglutamate-abeta 3\u201342 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model","volume":"118","author":"Wirths","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.nbd.2015.10.003_bb0375","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1089\/ars.2012.4905","article-title":"Regulation of the intrinsic apoptosis pathway by reactive oxygen species","volume":"19","author":"Wu","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.nbd.2015.10.003_bb0380","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00213-011-2291-7","article-title":"Neuroprotection of paliperidone on SH-SY5Y cells against beta-amyloid peptide(25\u201335), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death","volume":"217","author":"Yang","year":"2011","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.nbd.2015.10.003_bb0385","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/pr070501k","article-title":"Integrated analysis of the cerebrospinal fluid peptidome and proteome","volume":"7","author":"Zougman","year":"2008","journal-title":"J. Proteome Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T14:53:12Z","timestamp":1537282392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":77,"alternative-id":["S0969996115300607"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.10.003","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative stress and mitochondria-mediated cell death mechanisms triggered by the familial Danish dementia ADan amyloid","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}